Bayer AG (BAYN) PT Set at 126.00 by Sanford C. Bernstein
The firm currently has a "buy" rating on the healthcare company's stock. BAYN has been the subject of a number of other research reports.
from Biotech News
The firm currently has a "buy" rating on the healthcare company's stock. BAYN has been the subject of a number of other research reports.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments